Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00213759Phase 3Completed
A Phase 3 trial of filgrastim in neutropenia, sponsored by Strasbourg University Hospital. Started Mar 2002; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00213759.